Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05848271 · ClinicalTrials.gov registry record

Natural History Study of Patients with HPDL Mutations

A clinical trial of Genetic Disease and Neonatal Encephalopathy, sponsored by University of California, San Diego.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT05848271 is a study of Genetic Disease and Neonatal Encephalopathy that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 2,560-participant average among 30 other Genetic Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05848271, a study of Genetic Disease and Neonatal Encephalopathy, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations

Interventions

  • OTHER Patient Registry
  • OTHER Dry blood spots sampling

Study Locations (1)

California

  • Eun Hae Lee - San Diego

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-18
Est. Completion 2027-12-31

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05848271

The ClinicalTrials.gov registry entry for NCT05848271 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,560-participant average among 30 other Genetic Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Genetic Disease appearing as the primary indexed condition, and to 2 interventions - of which Patient Registry is the first listed.

NCT05848271 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05848271 about?

NCT05848271 is a clinical study titled "Natural History Study of Patients with HPDL Mutations". This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations

What is the current status of trial NCT05848271?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2023-05-18. Estimated completion is 2027-12-31.

What conditions does trial NCT05848271 study?

This clinical trial studies the following conditions: Genetic Disease, Neonatal Encephalopathy, Hereditary Spastic Paraplegia, White Matter Disease, Mitochondrial Encephalomyopathies.

What interventions are being tested in trial NCT05848271?

The interventions under investigation include: Patient Registry (OTHER), Dry blood spots sampling (OTHER).

Who is sponsoring clinical trial NCT05848271?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05848271 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.